Dynamic contrast-enhanced magnetic resonance imaging in the assessment of early response to tumor necrosis factor alpha in a colon carcinoma model

Jin Shan Tang, Garry Choy, Marcelino Bernardo, David Thomasson, Steven K. Libutti, Peter L. Choyke

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

OBJECTIVE: We describe the effects of tumor necrosis factor alpha (TNFα) on tumor microvasculature in a murine colon carcinoma model using serial dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI). MATERIAL AND METHODS: Mice with subcutaneous murine colon carcinomas (MC-38) were imaged at 4.7 T after administration of 0.2 mmol/kg gadolinium-DTPA. Both treated and control mice (each group, n = 4), were scanned at baseline and 2, 4, 6, and 96 hours. A 2-compartment pharmacokinetic model generated parameters such as K, kep, and initial area under the gadolinium concentration curve (IAUC). RESULTS: The treatment group revealed significant differences in K at all time points after TNFα. kep and IAUC were significantly reduced at 2, 6, and 96 hours. The coefficient of variation in control animals ranged from 0.13 for IAUC to 0.30 for K. Mild histologic changes were observed at 2 to 6 hours, but considerable central necrosis with a vascular tumor rim was seen at 96 hours. CONCLUSION: DCE MRI can be used to detect early effects of TNFα. Serial DCE MRI is a promising tool in assessing the early effects of antivascular therapies.

Original languageEnglish (US)
Pages (from-to)691-696
Number of pages6
JournalInvestigative Radiology
Volume41
Issue number9
DOIs
StatePublished - Sep 2006
Externally publishedYes

Fingerprint

Gadolinium
Colon
Tumor Necrosis Factor-alpha
Magnetic Resonance Imaging
Carcinoma
Gadolinium DTPA
Microvessels
Blood Vessels
Neoplasms
Necrosis
Pharmacokinetics
Therapeutics

Keywords

  • Angiogenic inhibitor
  • Antivascular therapy TNFα
  • Coefficients of variation
  • DCE MRI
  • General kinetic model
  • Tumor

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Dynamic contrast-enhanced magnetic resonance imaging in the assessment of early response to tumor necrosis factor alpha in a colon carcinoma model. / Tang, Jin Shan; Choy, Garry; Bernardo, Marcelino; Thomasson, David; Libutti, Steven K.; Choyke, Peter L.

In: Investigative Radiology, Vol. 41, No. 9, 09.2006, p. 691-696.

Research output: Contribution to journalArticle

Tang, Jin Shan ; Choy, Garry ; Bernardo, Marcelino ; Thomasson, David ; Libutti, Steven K. ; Choyke, Peter L. / Dynamic contrast-enhanced magnetic resonance imaging in the assessment of early response to tumor necrosis factor alpha in a colon carcinoma model. In: Investigative Radiology. 2006 ; Vol. 41, No. 9. pp. 691-696.
@article{a3d244576622476695e9d15b64dd7c2c,
title = "Dynamic contrast-enhanced magnetic resonance imaging in the assessment of early response to tumor necrosis factor alpha in a colon carcinoma model",
abstract = "OBJECTIVE: We describe the effects of tumor necrosis factor alpha (TNFα) on tumor microvasculature in a murine colon carcinoma model using serial dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI). MATERIAL AND METHODS: Mice with subcutaneous murine colon carcinomas (MC-38) were imaged at 4.7 T after administration of 0.2 mmol/kg gadolinium-DTPA. Both treated and control mice (each group, n = 4), were scanned at baseline and 2, 4, 6, and 96 hours. A 2-compartment pharmacokinetic model generated parameters such as K, kep, and initial area under the gadolinium concentration curve (IAUC). RESULTS: The treatment group revealed significant differences in K at all time points after TNFα. kep and IAUC were significantly reduced at 2, 6, and 96 hours. The coefficient of variation in control animals ranged from 0.13 for IAUC to 0.30 for K. Mild histologic changes were observed at 2 to 6 hours, but considerable central necrosis with a vascular tumor rim was seen at 96 hours. CONCLUSION: DCE MRI can be used to detect early effects of TNFα. Serial DCE MRI is a promising tool in assessing the early effects of antivascular therapies.",
keywords = "Angiogenic inhibitor, Antivascular therapy TNFα, Coefficients of variation, DCE MRI, General kinetic model, Tumor",
author = "Tang, {Jin Shan} and Garry Choy and Marcelino Bernardo and David Thomasson and Libutti, {Steven K.} and Choyke, {Peter L.}",
year = "2006",
month = "9",
doi = "10.1097/01.rli.0000233882.83800.fb",
language = "English (US)",
volume = "41",
pages = "691--696",
journal = "Investigative Radiology",
issn = "0020-9996",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Dynamic contrast-enhanced magnetic resonance imaging in the assessment of early response to tumor necrosis factor alpha in a colon carcinoma model

AU - Tang, Jin Shan

AU - Choy, Garry

AU - Bernardo, Marcelino

AU - Thomasson, David

AU - Libutti, Steven K.

AU - Choyke, Peter L.

PY - 2006/9

Y1 - 2006/9

N2 - OBJECTIVE: We describe the effects of tumor necrosis factor alpha (TNFα) on tumor microvasculature in a murine colon carcinoma model using serial dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI). MATERIAL AND METHODS: Mice with subcutaneous murine colon carcinomas (MC-38) were imaged at 4.7 T after administration of 0.2 mmol/kg gadolinium-DTPA. Both treated and control mice (each group, n = 4), were scanned at baseline and 2, 4, 6, and 96 hours. A 2-compartment pharmacokinetic model generated parameters such as K, kep, and initial area under the gadolinium concentration curve (IAUC). RESULTS: The treatment group revealed significant differences in K at all time points after TNFα. kep and IAUC were significantly reduced at 2, 6, and 96 hours. The coefficient of variation in control animals ranged from 0.13 for IAUC to 0.30 for K. Mild histologic changes were observed at 2 to 6 hours, but considerable central necrosis with a vascular tumor rim was seen at 96 hours. CONCLUSION: DCE MRI can be used to detect early effects of TNFα. Serial DCE MRI is a promising tool in assessing the early effects of antivascular therapies.

AB - OBJECTIVE: We describe the effects of tumor necrosis factor alpha (TNFα) on tumor microvasculature in a murine colon carcinoma model using serial dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI). MATERIAL AND METHODS: Mice with subcutaneous murine colon carcinomas (MC-38) were imaged at 4.7 T after administration of 0.2 mmol/kg gadolinium-DTPA. Both treated and control mice (each group, n = 4), were scanned at baseline and 2, 4, 6, and 96 hours. A 2-compartment pharmacokinetic model generated parameters such as K, kep, and initial area under the gadolinium concentration curve (IAUC). RESULTS: The treatment group revealed significant differences in K at all time points after TNFα. kep and IAUC were significantly reduced at 2, 6, and 96 hours. The coefficient of variation in control animals ranged from 0.13 for IAUC to 0.30 for K. Mild histologic changes were observed at 2 to 6 hours, but considerable central necrosis with a vascular tumor rim was seen at 96 hours. CONCLUSION: DCE MRI can be used to detect early effects of TNFα. Serial DCE MRI is a promising tool in assessing the early effects of antivascular therapies.

KW - Angiogenic inhibitor

KW - Antivascular therapy TNFα

KW - Coefficients of variation

KW - DCE MRI

KW - General kinetic model

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=33747060166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747060166&partnerID=8YFLogxK

U2 - 10.1097/01.rli.0000233882.83800.fb

DO - 10.1097/01.rli.0000233882.83800.fb

M3 - Article

C2 - 16896304

AN - SCOPUS:33747060166

VL - 41

SP - 691

EP - 696

JO - Investigative Radiology

JF - Investigative Radiology

SN - 0020-9996

IS - 9

ER -